Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.
Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.
